| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
metastasis associated 1 | 0.547 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0.949 | 1 | 0 | 1994 | 2019 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
phenotype | 0.100 | None | 0.950 | 3 | 0 | 2003 | 2018 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
phenotype | 0.100 | None | 0.951 | 2 | 0 | 1997 | 2019 | ||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
phenotype | 0.100 | None | 0.952 | 2 | 0 | 1992 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.952 | 1 | 0 | 1991 | 2020 | ||||||||
|
TIMP metallopeptidase inhibitor 2 | 0.425 | 0.846 | 0.79 |
|
phenotype | 0.100 | None | 0.953 | 3 | 0 | 1993 | 2019 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
phenotype | 0.100 | None | 0.955 | 2 | 0 | 2003 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
phenotype | 0.100 | None | 0.955 | 1 | 0 | 2004 | 2019 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.955 | 1 | 0 | 2007 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.100 | None | 0.957 | 4 | 0 | 2000 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
phenotype | 0.100 | None | 0.957 | 1 | 0 | 1996 | 2019 | ||||||||
|
activated leukocyte cell adhesion molecule | 0.502 | 0.808 | 0.73 |
|
phenotype | 0.100 | None | 0.957 | 1 | 0 | 2004 | 2019 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
phenotype | 0.100 | None | 0.958 | 1 | 0 | 1999 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.959 | 3 | 0 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.959 | 1 | 0 | 1990 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.400 | None | 0.960 | 15 | 0 | 1993 | 2020 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
phenotype | 0.100 | None | 0.960 | 2 | 0 | 2004 | 2019 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
phenotype | 0.400 | None | 0.960 | 2 | 0 | 1996 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 3 | 0.436 | 0.808 | 0.18 |
|
phenotype | 0.100 | None | 0.960 | 1 | 0 | 2004 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 6 | 0 | 1996 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 5 | 0 | 1992 | 2020 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.400 | None | 0.962 | 3 | 0 | 1992 | 2020 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 0.962 | 2 | 0 | 1996 | 2020 | ||||||||
|
TNF superfamily member 11 | 0.453 | 0.846 | 4.9E-03 |
|
phenotype | 0.100 | None | 0.963 | 5 | 0 | 2003 | 2020 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
phenotype | 0.100 | None | 0.963 | 1 | 0 | 1994 | 2020 |